These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27343418)
1. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients". Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418 [TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up. Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385 [TBL] [Abstract][Full Text] [Related]
3. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres. Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357 [TBL] [Abstract][Full Text] [Related]
4. Magnesium versus poly-L-lactic acid bioresorbable scaffolds: in vivo optical coherence tomography comparison of mechanical performance. Abellás-Sequeiros RA; Ocaranza-Sanchez R; Galvaõ-Braga C; Marques J; Gonzalez-Juanatey C Arch Cardiol Mex; 2020; 90(1):8-15. PubMed ID: 31996867 [TBL] [Abstract][Full Text] [Related]
6. Performing percutaneous coronary interventions with predilatation using non-compliant balloons at high-pressure versus conventional semi-compliant balloons: insights from two randomised studies using optical coherence tomography. Cuculi F; Bossard M; Zasada W; Moccetti F; Voskuil M; Wolfrum M; Malinowski KP; Toggweiler S; Kobza R Open Heart; 2020; 7(1):e001204. PubMed ID: 32076567 [TBL] [Abstract][Full Text] [Related]
7. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. Onuma Y; Sotomi Y; Shiomi H; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Igarashi K; Kozuma K; Tanabe K; Kusano H; Rapoza R; Popma JJ; Stone GW; Simonton C; Serruys PW; Kimura T EuroIntervention; 2016 Oct; 12(9):1090-1101. PubMed ID: 27597270 [TBL] [Abstract][Full Text] [Related]
8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
9. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction. Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds. Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705 [TBL] [Abstract][Full Text] [Related]
11. Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registry. Cortese B; di Palma G; Cerrato E; Latini RA; Elwany M; Orrego PS; Seregni RG J Interv Cardiol; 2017 Oct; 30(5):427-432. PubMed ID: 28853189 [TBL] [Abstract][Full Text] [Related]
12. Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment. De Paolis M; Felix C; van Ditzhuijzen N; Fam JM; Karanasos A; de Boer S; van Mieghem NM; Daemen J; Costa F; Bergoli LC; Ligthart JM; Regar E; de Jaegere PP; Zijlstra F; van Geuns RJ; Diletti R Int J Cardiol; 2016 Oct; 221():656-64. PubMed ID: 27423087 [TBL] [Abstract][Full Text] [Related]